ReShape Lifesciences (RSLS) News Today $2.38 -0.06 (-2.46%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.40 +0.02 (+0.63%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock RSLS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period ReShape Lifesciences provides $200,000 loan to Vyome Therapeutics under merger terms - Investing.comJuly 5, 2025 | investing.comReShape Lifesciences Loans $200K to Vyome TherapeuticsJuly 3, 2025 | tipranks.comReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon SystemJuly 1, 2025 | globenewswire.comReShape Lifesciences Inc (RSLS) Stock Forums - Investing.comJune 28, 2025 | investing.comReShape Lifesciences Inc: ReShape Lifesciences Regains Compliance with Nasdaq Minimum Stockholders Equity RequirementJune 27, 2025 | finanznachrichten.deReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with ... - MorningstarJune 27, 2025 | morningstar.comMReShape Lifesciences® Regains Compliance with Nasdaq Minimum Stockholders Equity RequirementJune 27, 2025 | globenewswire.comRSLS - Reshape Lifesciences Inc Executives - MorningstarJune 26, 2025 | morningstar.comMRSLS - Reshape Lifesciences Inc Valuation - MorningstarJune 26, 2025 | morningstar.comMReShape Lifesciences receives Australian patent for diabetes deviceJune 26, 2025 | investing.comReShape Lifesciences® Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad MedisysJune 26, 2025 | globenewswire.comReShape Lifesciences® Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation TechnologyJune 25, 2025 | globenewswire.comReShape Lifesciences Raises Equity to Avoid DelistingJune 18, 2025 | tipranks.comReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail ApplauseJune 13, 2025 | msn.comReShape Lifesciences Inc: ReShape Lifesciences Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD MarketsJune 12, 2025 | finanznachrichten.deReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD MarketsJune 12, 2025 | globenewswire.comReShape Lifesciences® Announces Pricing of Public Offering of Common Stock Raising Approximately $2.6 MillionJune 11, 2025 | nasdaq.comReShape Lifesciences Stock Slumps As Company Prices Public Offering At Significant Discount: Retail Holds On To OptimismJune 10, 2025 | msn.comReShape Lifesciences® Announces Pricing of $2.6 Million Public OfferingJune 9, 2025 | globenewswire.comReShape Lifesciences Stock Soars On Regulatory Certification For Medical Devices In EU, UK: Retail Eyes Fair ValuationJune 4, 2025 | msn.comReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product PortfolioJune 3, 2025 | globenewswire.comReShape Lifesciences announces merger progressMay 30, 2025 | uk.investing.comReShape Lifesciences® Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate UpdateMay 21, 2025 | globenewswire.comReShape Lifesciences (NASDAQ:RSLS) Stock Passes Above Two Hundred Day Moving Average - Here's WhyMay 12, 2025 | marketbeat.comReShape Lifesciences Inc: ReShape Lifesciences Announces 1-for-25 Reverse Stock SplitMay 7, 2025 | finanznachrichten.deReShape Lifesciences Announces 1-for-25 Reverse Stock SplitMay 7, 2025 | globenewswire.comStocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock ChatterMay 5, 2025 | msn.comPRISM Mid-Day Movers: Weight Loss Index Gains on Positive Data, Biotech Slumps on Disappointing ResultsMay 3, 2025 | theglobeandmail.comReShape Lifesciences® Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation SymposiumMay 2, 2025 | globenewswire.comReShape Lifesciences amends asset purchase terms with NinjourApril 30, 2025 | investing.comReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon SystemApril 28, 2025 | finanznachrichten.deReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon SystemApril 28, 2025 | globenewswire.comReShape Lifesciences® Secures Patent for Innovative Vagal Neuromodulation Device to Treat Type 2 Diabetes with Enhanced Energy EfficiencyApril 23, 2025 | nasdaq.comReShape Lifesciences Ignites Retail Frenzy As Stock Soars On US Patent For Diabetes Neuromodulation SystemApril 22, 2025 | msn.comReShape Lifesciences skyrockets after receiving U.S. patent for diabetes neuromodulation technologyApril 21, 2025 | msn.comReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation TechnologyApril 21, 2025 | globenewswire.comReShape Lifesciences enters agreement with HaifaApril 10, 2025 | markets.businessinsider.comReShape Lifesciences Inc. (RSLS) Earnings Highlights and Strategic Business Update Conference (Transcript)April 10, 2025 | seekingalpha.comReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. MarketApril 9, 2025 | globenewswire.comReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate UpdateApril 7, 2025 | globenewswire.comReShape Lifesciences Delays Yearly Report FilingApril 1, 2025 | tipranks.comRESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLSMarch 21, 2025 | businesswire.comReShape Lifesciences® Receives Notice of Allowance for Vagus Nerve Modulation Patent Aimed at Improving Glycemic ControlMarch 12, 2025 | nasdaq.comReShape receives notice of allowance for patent related to NeuromodulationMarch 10, 2025 | markets.businessinsider.comReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation TechnologyMarch 10, 2025 | globenewswire.comReShape Lifesciences signs distribution agreement with Liaison MedicalFebruary 25, 2025 | markets.businessinsider.comReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEXFebruary 25, 2025 | globenewswire.comReShape Lifesciences 2.6M share Secondary priced at $2.33February 18, 2025 | markets.businessinsider.comReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public OfferingFebruary 15, 2025 | globenewswire.comRSLS stock touches 52-week low at $2.57 amid market challengesFebruary 13, 2025 | msn.com Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address RSLS Media Mentions By Week RSLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.930.99▲Average Medical News Sentiment RSLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼11▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BIAF News ABT News ISRG News BSX News SYK News MDT News BDX News EW News IDXX News RMD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RSLS) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RSLS Stock Alerts